Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Kifunensine

EU orphan designation number: EU/3/11/906   
Active ingredient: Kifunensine
Indication: Treatment of beta-sarcoglycanopathy
Sponsor: Généthon
1 bis rue de l’internationale, F-91000 Evry, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/09/2011 Centralised Orphan - Designation EMA/OD/059/11 (2011)7039 of 27/09/2011